112
Participants
Start Date
August 18, 2020
Primary Completion Date
July 21, 2022
Study Completion Date
December 1, 2022
SEL-212 low-dose
IV infusion of SEL-212 low-dose every 28 days for a total of up to 12 infusions
SEL-212 high-dose
IV infusion of SEL-212 high-dose every 28 days for a total of up to 12 infusions
Normal Saline
IV infusion of Normal Saline every 28 days for a total of up to 12 infusions
Medex Healthcare Research, Inc., New York
Klein and Associates, M.D., P.A., Cumberland
Klein and Associates, M.D., P.A., Hagerstown
Clinical Research Partners, LLC, Richmond
CFA - Cape Fear Arthritis Care, PLLC, Leland
Better Health Clinical Research, Inc., Newnan
Riverside Clinical Research, Edgewater
Omegas Research Consultants LLC, DeBary
Conquest Research, Winter Park
Panax Clinical Research, Miami Lakes
Homestead Associates in Research,Inc, Homestead
Y & L Advance Health Care, Inc, Miami
Well Pharma Medical Research, Corp, Miami
Helix Biomedics, LLC, Boynton Beach
Health Awareness INC, Jupiter
Clinical Research of West Florida, Inc., Tampa
Clinical Research Of West Florida Incorporated, Clearwater
Pinnacle Research Group, Anniston
West Tennessee Research Institute, Jackson
Elite Clinical Research, LLC, Jackson
L-MARC Research Center, Louisville
Research Integrity, LLC, Owensboro
New Horizons Clinical Research, Cincinnati
Montana Medical Research, Inc., Missoula
Arthritis Consultants, Inc., St Louis
Arthritis & Rheumatology Center of Oklahoma, PLLC, Oklahoma City
Southwest Rheumatology Research LLC, Mesquite
Epic Medical Research, Red Oak
Metroplex Clinical Research Center, Dallas
AIM Trials - Internal Medicine, Plano
Pioneer Research Solutions, Inc., Houston
Tekton Research - Fort Collins, Fort Collins
Institute of Arthritis Research, Idaho Falls
Advanced Clinical Research (ACR) - Family Practice/General Medicine - Meridian, Meridian
Arizona Arthritis & Rheumatology Research, PLLC, Sun City
Valerius Medical Group & Research Center, Los Alamitos
Medvin Clinical Research, Covina
ACRC Studies, Poway
MD Strategies Research Center, San Diego
Clinical Pharmacology Study Group, Worcester
Lead Sponsor
Swedish Orphan Biovitrum
INDUSTRY